About
Antibody Discovery Technology
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
167
By Phase
PHASE2/PHASE3: 1PHASE1: 2
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05769582Lead Sponsor
Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients
PHASE2/PHASE3Completed
95 participants
Started: Apr 10, 2023 · Completed: Jul 15, 2025
NCT05358106Lead Sponsor
Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.
PHASE1Completed
40 participants
Started: May 9, 2022 · Completed: Apr 2, 2023
NCT05351437Lead Sponsor
To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.
PHASE1Completed
32 participants
Started: Apr 26, 2022 · Completed: Nov 2, 2022
Locations (1)
Headquarters
Schlieren, Switzerland
Map
Loading map...